CETA update from LeadNow

February 17, 2017

Some bad news, and some good news. The bad news is that, this week, both the European Parliament and the Canadian House of Commons ignored public opposition by passing CETA – a risky and extreme trade and investment deal that will cost thousands of jobs, drive up the cost of pharmaceutical drugs, and allow multinationals to sue us for millions when our laws affect their profits. What’s worse, Canada’s Trade…

Read More >>